CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Dyclonine HCl 50mg  | ≥99%

CSNpharm

Dyclonine HCl is the HCl form of dyclonine which can reversibly bind to activated sodium channels on the neuronal membrane. It is an anaesthetic found in sucrets.

More Information Supplier Page

DZ2002 5mg  | ≥98%

CSNpharm

DZ2002 is a potent and reversible S-adenosyl-L-homocysteine hydrolase (SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.

More Information Supplier Page

DZ2002 50mg  | ≥98%

CSNpharm

DZ2002 is a potent and reversible S-adenosyl-L-homocysteine hydrolase (SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.

More Information Supplier Page

DZ2002 100mg  | ≥98%

CSNpharm

DZ2002 is a potent and reversible S-adenosyl-L-homocysteine hydrolase (SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.

More Information Supplier Page

DZ2002 10mg  | ≥98%

CSNpharm

DZ2002 is a potent and reversible S-adenosyl-L-homocysteine hydrolase (SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.

More Information Supplier Page

DZ2002 25mg  | ≥98%

CSNpharm

DZ2002 is a potent and reversible S-adenosyl-L-homocysteine hydrolase (SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.

More Information Supplier Page

DZ2002 1mg  | ≥98%

CSNpharm

DZ2002 is a potent and reversible S-adenosyl-L-homocysteine hydrolase (SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.

More Information Supplier Page

E-64 25mg  | ≥99%

CSNpharm

E-64 is a potent irreversible inhibitor against general cysteine proteases with IC50 of 9 nM for papain.

More Information Supplier Page

E-64 5mg  | ≥99%

CSNpharm

E-64 is a potent irreversible inhibitor against general cysteine proteases with IC50 of 9 nM for papain.

More Information Supplier Page

E-64 50mg  | ≥99%

CSNpharm

E-64 is a potent irreversible inhibitor against general cysteine proteases with IC50 of 9 nM for papain.

More Information Supplier Page

E-64 10mg  | ≥99%

CSNpharm

E-64 is a potent irreversible inhibitor against general cysteine proteases with IC50 of 9 nM for papain.

More Information Supplier Page

E-7046 50mg  | ≥99%

CSNpharm

E7046 is a specific antagonist of the type 4 prostaglandin E2 (PGE2) receptor EP4. It possesses significant antitumor growth activity in multiple preclinical tumor models through modulating myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells.

More Information Supplier Page

E-7046 5mg  | ≥99%

CSNpharm

E7046 is a specific antagonist of the type 4 prostaglandin E2 (PGE2) receptor EP4. It possesses significant antitumor growth activity in multiple preclinical tumor models through modulating myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells.

More Information Supplier Page

E-7046 25mg  | ≥99%

CSNpharm

E7046 is a specific antagonist of the type 4 prostaglandin E2 (PGE2) receptor EP4. It possesses significant antitumor growth activity in multiple preclinical tumor models through modulating myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells.

More Information Supplier Page

E-7046 10mg  | ≥99%

CSNpharm

E7046 is a specific antagonist of the type 4 prostaglandin E2 (PGE2) receptor EP4. It possesses significant antitumor growth activity in multiple preclinical tumor models through modulating myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells.

More Information Supplier Page

E3 ligase Ligand 1 100mg  | ≥98%

CSNpharm

E3 ligase Ligand 1 is a VH032 derivate for conjugation reactions of PROTAC, which can hijack VHL as the E3 ubiquitin ligase component.

More Information Supplier Page

E3 ligase Ligand 2 1g  | ≥99%

CSNpharm

E3 ligase Ligand 2 is a thalidomide derivate for conjugation reactions of PROTAC, which can hijack cereblon as the E3 ubiquitin ligase component.

More Information Supplier Page

E3 ligase Ligand 2 100mg  | ≥99%

CSNpharm

E3 ligase Ligand 2 is a thalidomide derivate for conjugation reactions of PROTAC, which can hijack cereblon as the E3 ubiquitin ligase component.

More Information Supplier Page

EBPC 100mg  | ≥98%

CSNpharm

EBPC is a potent aldose reductase inhibitor which inhibits PGF2α production, enhances ERK activity and potentiates anticancer effects of cisplatin and doxorubicin.

More Information Supplier Page

Ebselen 5mg  | ≥99%

CSNpharm

Ebselen is a small-molecule capsid inhibitor of HIV-1 replication with anti-inflammatory, anti-oxidant and cytoprotective activity.

More Information Supplier Page

Ebselen 50mg  | ≥99%

CSNpharm

Ebselen is a small-molecule capsid inhibitor of HIV-1 replication with anti-inflammatory, anti-oxidant and cytoprotective activity.

More Information Supplier Page

Ebselen 100mg  | ≥99%

CSNpharm

Ebselen is a small-molecule capsid inhibitor of HIV-1 replication with anti-inflammatory, anti-oxidant and cytoprotective activity.

More Information Supplier Page

Ebselen 10mg  | ≥99%

CSNpharm

Ebselen is a small-molecule capsid inhibitor of HIV-1 replication with anti-inflammatory, anti-oxidant and cytoprotective activity.

More Information Supplier Page